Tuesday, February 15, 2022

What the Moderna share price reveals about vaccines

Now this is interesting. Here is Freddie Sayers of UnHerd TV discussing the topic of the title of this post with a well known Wall St financial analyst. The most interesting thing that becomes apparent in this conversation is something we might call the "profit to efficacy ratio", or said another way, the "bang for the buck" ratio.

If you're following markets at all (home prices, stock prices, etc) you may also know that many price metrics are at historically high extremes. We may have another example of that right here!

Legacy media will never be able to walk this one back.

No comments:

Post a Comment